arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Programme

Thursday 05 Nov

08:30

Registration

09:00

Opening/welcome

René Leemans/Andreas Dietz/Wojciech Golusinski

Epidemiology and carcinogenesis

Chairs: Andreas Dietz/Wojciech Golusinski

09:30

Epidemiology of oral/oropharyngeal HPV infection

Maura Gillisson (to be confirmed)

09:50

HPV-mediated carcinogenesis

Ruud Brakenhoff

10:10

World wide incidence of HPV in OPSCC

Pawel Golusinski

10:30

EMT and stem cells in HPV HNSCC

Jochen Hess

10:50

Coffee

11:20

Free papers

Prognostic impact HPV in OPSCC

Chairs: Ruud Brakenhoff/ Maura Gillison

12:00

Validation of statistical models for OPSCC

Robert Baatenburg de Jong

12:20

HPV risk modeling 2.0

Gunnar Wichman

12:40

Subclassification of HPV-OPSCC by gene expression

Lisa Licitra

13:00

Lunch (symposium)

Treatment of HPV+ve OPSCC

Chairs: René Leemans/Bob Ferris

14:00

Treatment of HPV disease by transoral robotic surgery

Christian Simon

14:20

Treatment of HPV disease by laser surgery

Terry Jones

14:40

Treatment of HPV disease with (chemo)radiotherapy

Vincent Gregoire

15:00

Free papers

15:30

Coffee

Session title to be announced

Chairs: Christian Simon/Stephan Lang

16:00

Are there alternatives for 3 weekly cisplatin in HPV disease

Jan Vermorken

16:20

Salvage surgery for HPV disease

Carole Fakhry

16:40

Debate: This house believes that TNM8 was implemented too early for HPV+ve OPSCC

For: Hisham Mehanna/Against: Brian O’Sullivan (to be confirmed)

17:00

Posters and Drinks

19:00

Social evening

Friday 06 Nov

Therapy developments in HPV+ve OPSCC

Chairs: Jan Vermorken/Vincent Gregoire

09:00

Free papers

09:30

De-escalation of non-surgical therapy

Hisham Mehanna

09:50

De-escalation using surgery

Bob Ferris (to be confirmed)

10:10

Is proton therapy preferable for HPV+ve OPSCC?

Hans Langendijk

10:30

Coffee

Session title to be announced

Chairs: Lisa Licitra/Hans Langendijk

11:00

Free papers

11:20

Next generation robotics

Stephan Lang

11:40

Immunotherapy for HPV driven disease

Maura Gillison (to be confirmed)

12:00

Tumor board (moderator: Terry Jones)

Wojciech Golusinski, Stephan Lang, Hans Langendijk, Lisa Licitra, Bob Ferris

13:00

Lunch (symposium)

Future perspectives in HPV research

Chairs: Rieneke van de Ven/Ingeborg Tinhofer-Keilholz

14:00

Therapeutic HPV vaccination

Sjoerd van der Burg

14:20

HPV in non-oropharygeal HNSCC: does it play a role?

René Leemans

14:40

Free papers

Screening and Prevention

Chair: Andreas Dietz

15:10

Round Table screening and prevention

Discussion leader: Andreas Dietz

5-slide Pitch Hans Berkhof: Preventive vaccination, also in treated OPSCC patients?
5-slide Pitch Tim Waterboer: HPV serology for screening
5-slide Pitch Ingeborg Tinhofer-Keilholz: HPV DNA assays for screening
5-slide Pitch Carole Fakhry: Positively screened for HPV: which intervention?

16:00

Round table discussion: screening and prevention

16:30

Closing remarks

Wojciech Golunski

16:40

Adjourn